Brokerages Set $84.00 Target Price for Exponent, Inc. (EXPO)

Exponent, Inc. (NASDAQ:EXPO) has been given a consensus broker rating score of 1.67 (Buy) from the three brokers that provide coverage for the company, Zacks Investment Research reports. One research analyst has rated the stock with a hold recommendation and two have issued a strong buy recommendation on the company. Exponent’s rating score has improved by 28.3% in the last 90 days as a result of various analysts’ ratings changes.

Analysts have set a 1-year consensus price target of $84.00 for the company and are predicting that the company will post $0.62 EPS for the current quarter, according to Zacks. Zacks has also assigned Exponent an industry rank of 213 out of 265 based on the ratings given to its competitors.

Several analysts have recently commented on the stock. BidaskClub raised shares of Exponent from a “sell” rating to a “hold” rating in a report on Monday, February 5th. Cantor Fitzgerald reaffirmed a “buy” rating and issued a $82.00 price objective on shares of Exponent in a report on Sunday, November 5th. SunTrust Banks reaffirmed a “hold” rating and issued a $77.00 price objective on shares of Exponent in a report on Thursday, October 19th. Finally, Zacks Investment Research downgraded shares of Exponent from a “strong-buy” rating to a “hold” rating in a report on Tuesday, December 19th.

Hedge funds have recently added to or reduced their stakes in the company. Advisor Group Inc. boosted its holdings in Exponent by 15.4% during the second quarter. Advisor Group Inc. now owns 2,131 shares of the business services provider’s stock worth $124,000 after buying an additional 284 shares in the last quarter. Trexquant Investment LP purchased a new stake in Exponent during the third quarter worth $224,000. Cubist Systematic Strategies LLC purchased a new stake in Exponent during the third quarter worth $242,000. Stifel Financial Corp purchased a new stake in Exponent during the third quarter worth $249,000. Finally, Amalgamated Bank boosted its holdings in Exponent by 5.1% during the second quarter. Amalgamated Bank now owns 3,553 shares of the business services provider’s stock worth $207,000 after buying an additional 171 shares in the last quarter. 89.49% of the stock is currently owned by institutional investors and hedge funds.

Exponent (EXPO) opened at $72.10 on Monday. Exponent has a 52 week low of $56.35 and a 52 week high of $78.39. The stock has a market cap of $1,860.97, a P/E ratio of 47.43 and a beta of 0.72.

Exponent (NASDAQ:EXPO) last released its quarterly earnings data on Thursday, February 1st. The business services provider reported $0.47 EPS for the quarter, beating the consensus estimate of $0.42 by $0.05. The business had revenue of $82.72 million for the quarter, compared to the consensus estimate of $80.27 million. Exponent had a net margin of 11.88% and a return on equity of 17.81%. The business’s revenue for the quarter was up 13.7% on a year-over-year basis. During the same period in the prior year, the firm earned $0.39 EPS. research analysts forecast that Exponent will post 2.41 earnings per share for the current year.

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, March 23rd. Stockholders of record on Friday, March 2nd will be issued a $0.26 dividend. This is an increase from Exponent’s previous quarterly dividend of $0.21. This represents a $1.04 annualized dividend and a dividend yield of 1.44%. The ex-dividend date of this dividend is Thursday, March 1st. Exponent’s dividend payout ratio is 55.26%.

TRADEMARK VIOLATION WARNING: This piece was first posted by American Banking News and is the property of of American Banking News. If you are viewing this piece on another publication, it was illegally stolen and reposted in violation of U.S. and international copyright & trademark legislation. The original version of this piece can be viewed at https://www.americanbankingnews.com/2018/02/12/brokerages-set-84-00-target-price-for-exponent-inc-expo.html.

Exponent Company Profile

Exponent, Inc (Exponent), along with its subsidiaries, is a science and engineering consulting company. Exponent provides engineering and scientific consulting services to clients around the world. Its service offerings are provided on a project-by-project basis. It operates in two segments: Engineering and Other Scientific, and Environmental and Health.

Get a free copy of the Zacks research report on Exponent (EXPO)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for Exponent Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Exponent and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply